New VP appointment at Genentech
This article was originally published in Scrip
Genentech (US) has appointed Dr Morgan Sheng vice-president of neuroscience. In this newly created position, Dr Sheng will be responsible for directing neurobiology drug discovery efforts at the company and will oversee the department of neurobiology. He joins from the Massachusetts Institute of Technology, where he is Menicon professor of neuroscience at the Power Institute for Learning and Memory and RIKEN-MIT Neuroscience Research Center in the departments of brain and cognitive science, and biology.
You may also be interested in...
Despite leading multinational pharma firms including AstraZeneca again delivering double-digit growth in China, the impact of coronavirus and an expanding volume-based purchasing scheme begin to surface.
The study is designed to support the regulatory approval process in China and confirm that the safety and immunogenicity profile observed in German and US trials is comparable to that of Chinese participants, according to BioNTech.
The UK Department of Health and Social Care recently asked medical device and pharmaceutical companies to establish contingency measures in case of supply problems post-Brexit.